Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name H19
   Synonyms H19, ASM, ASM1, BWS, D11S813E, LINC00008, NCRNA00008, WT2
   Region GRCh38_11:1995176-2001470    Sequence
   Ensembl ENSG00000130600
   RefSeq NR_002196
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name multiple myeloma
   ICD-0-3 C42.1  M9732/3
   Methods qPCR, Western blot
   Sample bone marrow tissues, cell lines ( OPM-2, U266, KM3, XG1, JJN3, RPMI, U1996, H929, and MM1S)
   Expression Pattern up-regulated
   Function Description

H19 knockdown induced by shRNA transfection significantly inhibited proliferation, viability and colony formation in MM cells, as well as inactivated NF-kB pathway.combination treatment of H19 knockdown and NF-kB suppression (induced by specific inhibitor PDTC) produced synergistically inhibitory effects.patients with high expression of H19 had a lower survival rate.H19 was involved in MM cell growth. The linkage between H19 and NF-kB pathway may provide a novel interpretation for the mechanism of H19's growth regulation in MM.

   Pubmed ID 29273733
   Year 2017
   Title Knockdown of long non-coding RNA H19 inhibits multiple myeloma cell growth via NF-kB pathway.
   External Links
   Links for  H19 GenBank       HGNC       lncrnadb       Noncode
   Links for  multiple myeloma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.